Prot #EZH-108: A Phase 1, Open-Label Multi-Dose Two-Part Study to Characterize the Effects of a Strong CYP3A4 Inhibitor on the Steady-State Pharmacokinetics of Tazemetostat (EPZ-6438), And The Effects Of A Strong CYP3A4 Inducer on the Steady- State Pharma

Project: Research project

Project Details

StatusActive
Effective start/end date11/2/2011/2/23

Funding

  • Medpace Clinical Research LLC (Prot #EZH-108)
  • Epizyme, Inc. (Prot #EZH-108)